Evidence map›Paper›PMID 41732020›Full record

ReviewLab on a chip2026

Autonomous microfluidic labs: progress and prospects.

Suyash Damir, Fernando Delgado-Licona, Andrew deMello, Milad Abolhasani

Abstract readReview
In one paragraph

Review in Lab on a chip, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suyash DamirDepartment of Chemistry and Applied Biosciences, Institute of Chemical and Bioengineering, ETH Zurich, Vladimir-Prelog-Weg 1, Zürich 8093, Switzerland. andrew.demello@chem.ethz.ch.ORCID http://orcid.org/0009-0007-2793-9690
Fernando Delgado-LiconaDepartment of Chemical & Biomolecular Engineering, North Carolina State University, Raleigh, NC, USA. abolhasani@ncsu.edu.ORCID http://orcid.org/0000-0003-3555-3353
Andrew deMelloDepartment of Chemistry and Applied Biosciences, Institute of Chemical and Bioengineering, ETH Zurich, Vladimir-Prelog-Weg 1, Zürich 8093, Switzerland. andrew.demello@chem.ethz.ch.ORCID http://orcid.org/0000-0003-1943-1356
Milad AbolhasaniDepartment of Chemical & Biomolecular Engineering, North Carolina State University, Raleigh, NC, USA. abolhasani@ncsu.edu.ORCID http://orcid.org/0000-0002-8863-3085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global challenges such as climate change, escalating energy demands, and health equity require new scientific innovations able to deliver timely solutions. Self-driving laboratories (SDLs) combine robotics and lab automation with artificial intelligence to efficiently explore complex experimental spaces, reduce human effort, and speed up discovery through intelligent experimentation. Central to this transformation is responsible research acceleration (RRA). This ensures that advances are reproducible, transparent, and resource-efficient, and lays the foundation for sustainable innovation. Microfluidics, with its precise control of heat and mass transfer rates, minimal reagent use, and seamless integration with real-time sensing and automation, represents an ideal platform to embody RRA principles within SDLs. This perspective explores the synergy between microfluidics and autonomous experimentation, highlights key challenges, and proposes strategies for fully autonomous microfluidic workflows. We argue that flow-based platforms are essential to expedite discovery and that stronger academia-industry collaboration is critical in shortening the path from scientific insight to real-world implementation and impact.

Identifiers

PMID41732020
PMCPMC12930150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.